Activity of the hypothalamic – pituitary – adrenal axis in patients with rheumatoid arthritis
Authors:
R. Imrich
Authors place of work:
Molekulárno- medicínske centrum SAV, Ústav experimentálnej endokrinológie SAV Bratislava, Slovenská republika, riaditeľ prof. MU Dr. Iwar Klimeš, DrSc.
Published in the journal:
Vnitř Lék 2010; 56(12): 1271-1273
Category:
Celebration
Summary
The controlled data accumulated so far support only subtle alterations in hypothalamic– pituitary‑adrenal (HPA) axis function in rheumatoid arthritis (RA), mainly at the adrenal level, and particularly in a subset of premenopausal onset women. Consequences of the subtle HPA alterations in RA for the disease development remain unclear. From a broader perspective, the unresponsiveness of the HPA axis to chronic inflammation in RA can be simply considered an ongoing adaptation to chronic disease.
Key words:
hypothalamic-pituitary-adrenal axis – rheumatoid arthritis – chronic inflammation
Zdroje
1. Mastorakos G, Weber JS, Magiakou MA et al. Hypothalamic‑ pituitary‑adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin‑6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion. J Clin Endocrinol Metab 1994; 79: 934– 939.
2. Masi AT, Aldag JC. Integrated neuroendocrine immune risk factors in relation to rheumatoid arthritis: should rheumatologists now adopt a model of a multiyear, presymptomatic phase? Scand J Rheumatol 2005; 34: 342– 352.
3. Derijk RH. Single nucleotide polymorphisms related to HPA axis reactivity. Neuroimmunomodulation 2009; 16: 340– 352.
4. Fife M, Steer S, Fisher S et al. Association of familial and sporadic rheumatoid arthritis with a single corticotropin‑releasing hormone genomic region (8q12.3) haplotype. Arthritis Rheum 2002; 46: 75– 82.
5. Baerwald CG, Mok CC, Tickly M et al. Corticotropin releasing hormone (CRH) promoter polymorphisms in various ethnic groups of patients with rheumatoid arthritis. Z Rheumatol 2000; 59: 29– 34.
6. Donn R, Payne D, Ray D. Glucocorticoid receptor gene polymorphisms and susceptibility to rheumatoid arthritis. Clin Endocrinol (Oxf) 2007; 67: 342– 345.
7. Masi AT. Sex hormones and rheumatoid arthritis: cause or effect relationships in a complex pathophysiology? Clin Exp Rheumatol 1995; 13: 227– 240.
8. Straub RH, Paimela L, Peltomaa R et al. Inadequately low serum levels of steroid hormones in relation to interleukin‑6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis. Arthritis Rheum 2002; 46: 654– 662.
9. Herrmann M, Scholmerich J, Straub RH. Influence of cytokines and growth factors on distinct steroidogenic enzymes in vitro: a short tabular data collection. Ann NY Acad Sci 2002; 966: 166– 186.
10. Sternberg EM, Hill JM, Chrousos GP et al. Inflammatory mediator‑induced hypothalamic‑ pituitary‑adrenal axis activation is defective in streptococcal cell wall arthritis‑ susceptible Lewis rats. Proc Natl Acad Sci USA 1989; 86: 2374– 2378.
11. Harkness JA, Richter MB, Panayi GS et al. Circadian variation in disease activity in rheumatoid arthritis. Br Med J (Clin Res Ed) 1982; 284: 551– 554.
12. Gudbjörnsson B, Skogseid B, Oberg K et al. Intact adrenocorticotropic hormone secretion but impaired cortisol response in patients with active rheumatoid arthritis. Effect of glucocorticoids. J Rheumatol 1996; 23: 596– 602.
13. Kanik KS, Chrousos GP, Schumacher HR et al. Adrenocorticotropin, glucocorticoid, and androgen secretion in patients with new onset synovitis/ rheumatoid arthritis: relations with indices of inflammation. J Clin Endocrinol Metab 2000; 85: 1461– 1466.
14. Vogl D, Falk W, Dorner M et al. Serum levels of pregnenolone and 17- hydroxypregnenolone in patients with rheumatoid arthritis and systemic lupus erythematosus: relation to other adrenal hormones. J Rheumatol 2003; 30: 269– 275.
15. Chikanza IC, Petrou P, Kingsley G et al. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum 1992; 35: 1281– 1288.
16. Chikanza IC, Petrou P, Chrousos G et al. Excessive and dysregulated secretion of prolactin in rheumatoid arthritis: immunopathogenetic and therapeutic implications. Br J Rheumatol 1993; 32: 445– 448.
17. Eijsbouts A, van den Hoogen F, Laan R et al. Similar response of adrenocorticotrophic hormone, cortisol and prolactin to surgery in rheumatoid arthritis and osteoarthritis. Br J Rheumatol 1998; 37: 1138– 1139.
18. Gutiérrez MA, García ME, Rodriguez JA et al. Hypothalamic‑ pituitary‑adrenal axis function in patients with active rheumatoid arthritis: a controlled study using insulin hypoglycemia stress test and prolactin stimulation. J Rheumatol 1999; 26: 277– 281.
19. Imrich R, Rovensky J, Malis F et al. Low levels of dehydroepiandrosterone sulphate in plasma, and reduced sympathoadrenal response to hypoglycaemia in premenopausal women with rheumatoid arthritis. Ann Rheum Dis 2005; 64: 202– 206.
20. Templ E, Koeller M, Riedl M et al. Anterior pituitary function in patients with newly diagnosed rheumatoid arthritis. Br J Rheumatol 1996; 35: 350– 356.
21. Cutolo M, Foppiani L, Prete C et al. Hypothalamic‑ pituitary‑adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids. J Rheumatol 1999; 26: 282– 288.
22. Dekkers JC, Geenen R, Godaert GL et al. Experimentally challenged reactivity of the hypothalamic pituitary adrenal axis in patients with recently diagnosed rheumatoid arthritis. J Rheumatol 2001; 28: 1496– 1504.
23. Imrich R, Vlcek M, Aldag JC et al. An endocrinologist‛s view on relative adrenocortical insufficiency in rheumatoid arthritis. Ann NY Acad Sci 2010; 1193: 134– 138.
24. Deighton CM, Watson MJ, Walker DJ. Sex hormones in postmenopausal HLA‑identical rheumatoid arthritis discordant sibling pairs. J Rheumatol 1992; 19: 1663– 1667.
25. Heikkilä R, Aho K, Heliövaara M et al. Serum androgen‑ anabolic hormones and the risk of rheumatoid arthritis. Ann Rheum Dis 1998; 57: 281– 285.
26. Imrich R, Vigas M, Rovensky J et al. Adrenal plasma steroid relations in glucocorticoid‑ naive premenopausal rheumatoid arthritis patients during insulin‑induced hypoglycemia test compared to matched normal control females. Endocr Regul 2009; 43: 65– 73.
27. Cebecauer L, Radikova Z, Rovensky J et al. Increased prevalence and coincidence of antinuclear and antithyroid antibodies in the population exposed to high levels of polychlorinated pollutants cocktail. Endocr Regul 2009; 43: 75– 81.
Štítky
Diabetology Endocrinology Internal medicineČlánok vyšiel v časopise
Internal Medicine
2010 Číslo 12
Najčítanejšie v tomto čísle
- Extremly low SHBG level in consequence of Pro156Leu SHBG polymorphism – case reports of two women with polycystic ovary syndrome
- Pulmonary Langerhans cell histiocytosis – evaluation of the disease activity and treatment response using PET‑CT (SUVmax Pulmo/ SUVmax Hepar index). Description of own experience and literature review
- Activity of the hypothalamic – pituitary – adrenal axis in patients with rheumatoid arthritis
- HIV lipodystrophy